Navigation Links
Testosterone Patches Found To Increase Sexual Desire In Menopausal Women

Testosterone patches that are used in some men to help them improve their sexual performance// and give them the desired sexual characteristics. Apparently the same patches can be used in women whose ovaries have been surgically removed to increase their sexual desire and activity.

In a study published in Arch Intern Med. this month the authors have looked at 447 women diagnosed with hypoactive sexual desire disorder (HSDD) after ovarian surgery. The women were randomly assigned to receive either testosterone patches or a placebo patch for 24 weeks. The testosterone patches had three separate dose of testosterone.

Compared to the placebo, the intermediate-dose testosterone patch significantly improved sexual desire and increased the frequency of satisfying sexual activity whereas the lower testosterone dose offered no benefits. The higher dose was found to be no better than the intermediate dose testosterone patch.

There were no serious side effects to the patches. There however remains some anxiety in finding the right dose of testosterone and more research maybe required.

SOURCE: Archives of Internal Medicine, July 25, 2005. Safety and Efficacy of a Testosterone Patch for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

A Randomized, Placebo-Controlled Trial Glenn D. Braunstein, MD; Dale A. Sundwall, MD; Molly Katz, MD; Jan L. Shifren, MD; John E. Buster, MD; James A. Simon, MD; Gloria Bachman, MD; Oscar A. Aguirre, MD; Johna D. Lucas, MD; Cynthia Rodenberg, PhD; Akshay Buch, PhD; Nelson B. Watts, MD

Further Information on Medindia on Female Sexual Dysfunction

What is female sexual dysfunction?

Female Sexual dysfunction is an age-related, progressive and highly prevalent problem affecting nearly 30-50 percent of women globally. Sexual activity incorporates interpersonal relationships, each partner bringing
'"/>




Page: 1 2

Related medicine news :

1. Testosterone Replacement Therapy Safe If Monitored Appropriately
2. Low Testosterone Levels the Cause Of Depression In Men
3. The Use Of Testosterone Replacement Therapy Questioned
4. Depression In Men Could Be To Low Testosterone Levels
5. Testosterone patch for women Rejected For safety Reasons
6. Testosterone Therapy can improve sexual function in postmenopausal women
7. Fatherhood Found To Tame Men by Reducing Testosterone Levels
8. Testosterone levels could serve as a marker for determining risk of SIDS
9. Males Lifespan Shortened By Elevated Levels Of Testosterone
10. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
11. Low Testosterone Linked With Early Death
Post Your Comments:
(Date:7/9/2008)...l Research Warranted on Impact of Medicare Moderni...enges; Data Shows Possibility of,Longer Wait Times...y 9 /PRNewswire-USNewswire/ -- According to a new ...nal of the American Medical,Association (JAMA), ca...r,access to quality cancer care following the pass...
(Date:7/9/2008)...pneumococcal vaccine (Prevenar) was introduced in ... years later, the experiences have been published ...g decline in serious pneumococcal infections among...that can cause serious illnesses in some young chi...nia. Most of those who become ill are previously h...
(Date:7/9/2008)...c outcome after lumpectomy linked to depression, f...HealthDay News) -- A third of women who opt for br...n asymmetry between their breasts that greatly aff... Women whose affected breast looked noticeably dif...their cancer returning and to have symptoms of dep...
(Date:7/9/2008)...ed MCO Pharmacy Directors Will Move Razadyne and R...dyne is Launched, According to a New ...ass., July 9 /PRNewswire/ -- Decision Resources, o...rms for pharmaceutical and,healthcare issues, find...rtho McNeil,s Razadyne (galantamine) in December 2...
Breaking Medicine News(10 mins):Health News:Global Access Project (GAP) Study Examining Patients' Access to Cancer Care Featured in the Journal of the American Medical Association (JAMA) 2Health News:Vaccinated infants well-protected against severe pneumococcal infection in Norway 2Health News:Breast-Conserving Surgery Leaves Many Cancer Patients Disappointed 2Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 2Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 3
...ongly condemned the UPA-Left decision to introduce...tack' on meritorious// students deserving a berth ...protesting students at Chittaranjan National Medic...s will hold a massive demonstration against the Ce...
...lihood of a woman suffering from domestic violence...n the emergency department about the topic. This a...ealth problem would be stressed, reveals a study, ...ne, (May 22) JAMA/Archives journals. Reluctance to...
...ith metabolic syndrome are significantly more like...ults of a new study indicate//. Metabolic syndrom..., high blood pressure and low levels of 'good' (HD...drome is at an increased risk of developing corona...
...orld Health Organization, Dr Lee Jong-Wook, is a m...alth Organization (India) said here today.// Lee, ... and other deadly diseases, was the first WHO chie...ng as DG, PHO general secretary I S Gilada said. P...
Other Medicine News:Health News:Discussion On Domestic Violence Increased By Computer Based Screening 2Health News:Discussion On Domestic Violence Increased By Computer Based Screening 3
(Date:7/7/2008)...Newswire-FirstCall/ -- Pulmo BioTech Inc. (OTC,Bul...diary, PulmoScience,Inc. has completed the bio-dis...for the PulmoBind technology of Molecular Imaging ...maging uses a molecule designed to bond specifical...lmoBind, the chosen molecule,was designed to bond ...
(Date:7/7/2008)...ewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC,Bulle...d biopharmaceutical,company specializing in the pr...ay provided an operational update on the company,s...man clinical trial testing and,plans to proceed in... Five,successful human trials evaluating GeoVax AI...
(Date:7/7/2008)...July 7 /- The Leukemia & Lymphoma,Soc...dberg M.D., M.M.Sc.,of the James P. Wilmot Cancer...ter. Millennium Pharmaceuticals, The Takeda Oncolo...rst two years of the five-year program., The Scho...will support,Dr. Friedberg,s work on a new targete...
(Date:7/6/2008)...TI,s Marketing Authorization Application currently... SEATTLE, July 7 /- Cell Th... announced the publication of results from its,ran...itaxel poliglumex,CT-2103) with gemcitabine or vi...tatus 2) patients with previously untreated non-sm...
Breaking Medicine Technology:Pulmo BioTech Inc. Completes Bio-Distribution Studies 2Pulmo BioTech Inc. Completes Bio-Distribution Studies 3GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5A search for protection against chemotherapy cardiotoxicity 1693 1A search for protection against chemotherapy cardiotoxicity 1693 2Certain diseases birth defects may be linked to failure of protein recycling system 1691 1Certain diseases birth defects may be linked to failure of protein recycling system 1691 2Center for Consumer Freedom Releases Dont Sue Me Santa Christmas Cookie Liability Waiver 8633 1Center for Consumer Freedom Releases Dont Sue Me Santa Christmas Cookie Liability Waiver 8633 2ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20 3A Year End Report 8631 1ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20 3A Year End Report 8631 2ZONARE Ranked Best in KLAS as Hand Carried Ultrasound Vendor in 2007 Top20 3A Year End Report 8631 3
...007 - Medtronic, Inc.,(NYSE:MDT) today announced ...l Trial indicates that the trial has met its prima...nical Trial is a randomized, single-blind,trial ev...M) Drug,Eluting Coronary Stent as compared to the ...m Boston Scientific Corporation,(NYSE:BSX). ENDEAV...
...rget from Lexicon,s Genetic,Research -, THE WOODLA...-,Lexicon Pharmaceuticals, Inc. today reported res...antibodies directed to a,potential new target, ang...triglycerides and cholesterol. Research suggests t...may have therapeutic,application in the treatment ...
Other Medicine Technology:ENDEAVOR IV Clinical Trial Meets Primary Endpoint 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 3Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 4Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 5
Full Handle Laseredge Stab Blade Knife, 22.5 blade. Blade tip dimension: 10.7 mm x 1.8 mm x 4.2 mm.
19 Gauge. Reusable. Block of 4 each.
18 gauge curved. Fine tip. Lightweight design offers precise hemostasis. Pencil design minimizes tissue trauma and induced astigmatism. Knurled handle provides a sure grip and better manipulation.
Set consist of two 23 gauge, stainless steel probes with blunt tips. Probes are 18 cm (7.0 inches) long with 30.5 cm (12 inches) of flexible tubing (O.D. - 0.60 mm, I.D. - 0.30 mm) attached onto the
Medicine Products: